Estimating the Cost and Cost-Effectiveness for Obstetric Fistula Repair in Low-Income Countries

Obstetric fistula in low-income countries.

OBJECTIVE To identify, survey, and systematically review the current knowledge regarding obstetric fistula as a public health problem in low-income countries from the peer-reviewed literature. METHODS The Medline and Science Citation Index databases were searched to identify public health articles on obstetric fistula in low-income countries. Quantitative evidence-based papers were reviewed. ...

Cost-effectiveness analyses for injury prevention initiatives in low- and middle-income countries.

Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries.

Scale up of antiretroviral therapy (ART) in resource-limited settings has changed the face of human immunodeficiency virus (HIV) infection and dramatically reduced HIV-related mortality [1]. Despite major progress, however, approximately 50% of HIV-infected persons who live in resourcelimited settings do not yet know their HIV status [2]. Efforts to reduce the burden of HIV infection therefore ...

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness

BACKGROUND Cost-effectiveness rankings of health interventions are useful inputs for national healthcare planning and budgeting. Previous comprehensive rankings for low- and middle- income countries were undertaken in 2005 and 2006, accompanying the development of strategies for the Millennium Development Goals. We update the rankings using studies published since 2000, as strategies are being ...

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

To help reach the target of tuberculosis (TB) disease elimination by 2050, vaccine development needs to occur now. We estimated the impact and cost-effectiveness of potential TB vaccines in low- and middle-income countries using an age-structured transmission model. New vaccines were assumed to be available in 2024, to prevent active TB in all individuals, to have a 5-y to lifetime duration of ...